His primary areas of study are Surgery, Ovarian cancer, Stage, Hysterectomy and Internal medicine. His Surgery research incorporates elements of Stage IIIC, Cervical cancer and Disease. His study of Debulking is a part of Ovarian cancer.
His Stage study incorporates themes from Gynecologic oncology, Urology, Carcinoma, Radiology and Gynecology. Dennis S. Chi combines subjects such as Endometrial cancer and Adjuvant therapy with his study of Hysterectomy. His studies in Internal medicine integrate themes in fields like Gastroenterology and Oncology.
His main research concerns Surgery, Ovarian cancer, Internal medicine, Oncology and Debulking. Many of his research projects under Surgery are closely connected to In patient with In patient, tying the diverse disciplines of science together. He works mostly in the field of Ovarian cancer, limiting it down to topics relating to Chemotherapy and, in certain cases, Serous fluid, as a part of the same area of interest.
Dennis S. Chi regularly ties together related areas like Gastroenterology in his Internal medicine studies. His Debulking research is multidisciplinary, incorporating perspectives in Ovarian carcinoma, Perioperative, Radiology, Stage IIIC and Cohort. Dennis S. Chi interconnects Hysterectomy and Gynecology in the investigation of issues within Endometrial cancer.
Dennis S. Chi mostly deals with Surgery, Ovarian cancer, Debulking, Internal medicine and Chemotherapy. His Surgery research includes themes of Adverse effect and Cohort. His Ovarian cancer study combines topics from a wide range of disciplines, such as Resection, Disease and Diaphragmatic hernia, Hernia.
His Debulking research integrates issues from Complication, Retrospective cohort study, Cardiothoracic surgery and Ovary. His study ties his expertise on Oncology together with the subject of Internal medicine. The Chemotherapy study combines topics in areas such as Ovarian carcinoma, Serous fluid, Univariate analysis, Surgical oncology and Triage.
Dennis S. Chi mainly investigates Ovarian cancer, Surgery, Debulking, Chemotherapy and Internal medicine. His work deals with themes such as Algorithm, Disease, Triage and Hazard ratio, which intersect with Ovarian cancer. His Surgery research is multidisciplinary, relying on both Polypharmacy and Cohort.
The study incorporates disciplines such as Complication, Intensive care unit, Depression and Geriatrics in addition to Debulking. His Chemotherapy research includes elements of Cancer, Framingham Risk Score, Ovarian carcinoma, Contraindication and Retrospective cohort study. His work carried out in the field of Internal medicine brings together such families of science as Oncology and Robotic surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)
D. S. Chi;E. L. Eisenhauer;J. Lang;J. Huh.
Gynecologic Oncology (2006)
Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian Cancer
Jeff Boyd;Yukio Sonoda;Mark G. Federici;Faina Bogomolniy.
JAMA (2000)
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Dennis S. Chi;Eric L. Eisenhauer;Oliver Zivanovic;Yukio Sonoda.
Gynecologic Oncology (2009)
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis
Robert E. Bristow;Dennis S. Chi.
Gynecologic Oncology (2006)
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
Robert E. Bristow;Isha Puri;Dennis S. Chi.
Gynecologic Oncology (2009)
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center
Nadeem R. Abu-Rustum;Kaled Alektiar;Alexia Iasonos;Gali Lev.
Gynecologic Oncology (2006)
Peritoneal Metastases: Detection with Spiral CT in Patients with Ovarian Cancer
Fergus V. Coakley;Patricia H. Choi;Christina A. Gougoutas;Bhavana Pothuri.
Radiology (2002)
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
Dennis S. Chi;Kristina McCaughty;John P. Diaz;Jae Huh.
Cancer (2006)
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eric L. Eisenhauer;Nadeem R. Abu-Rustum;Yukio Sonoda;Douglas A. Levine.
Gynecologic Oncology (2006)
The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: Beyond removal of blue nodes
Joyce N. Barlin;Fady Khoury-Collado;Christine H. Kim;Mario M. Leitao.
Gynecologic Oncology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Northwell Health
New York University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of California, Irvine
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of New Brunswick
Bilkent University
Wuhan University
University of Münster
University of Surrey
University of Groningen
University College Dublin
King's College London
US Forest Service
Colorado State University
Emory University
University of Amsterdam
Northwestern University
United States Department of the Army
State University of New York
Fermilab